跳至主要内容
临床试验/NCT02488200
NCT02488200Unknown不适用

Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis

Herlev Hospital1 个研究点 分布在 1 个国家目标入组 1,400 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,400
试验地点
1
主要终点
Proportion of patients who start planned dialysis initiation as defined by the protocol

研究概览

简要总结

The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), modality choice and prognosis. In particular the following questions are to be answered.

  1. What factors influence unplanned DI?
  2. What factors influence choice of dialysis modality?
  3. What factors influence choice of dialysis access?
  4. Why do physicians start dialysis?
  5. What factors in the predialytic period and its immediate aftermath (the "peridialytic" period) influence prognosis?

详细描述

Patients All patients starting active end stage renal disease (ESRD) treatment at the participating centres and their satellite centres.

No. Patients: 1000.

  1. Patients who have received their recent predialysis care at another centre can be included if the previous centre's notes are available, otherwise not.
  2. Patients receiving a preemptive transplant are included, even if the transplant is performed at another centre. A patient questionnaire is not required for these patients.
  3. Africans are excluded (inaccurate estimated glomerular filtration rate (eGFR) calculation) Each patient is allocated a local identity number (1,2,3....). The local author keeps a registry of the true patient identity of each identity number for follow-up purposes. This registry is not to be used in any communication outside the centre.

Comment: Most patients have known chronic uremia at dialysis start. In a few cases, it is unknown whether the uremia is acute or chronic. There are two main groups:

  1. Acute uremia of unknown origin. Doctors should fill the questionnaire in Table 2, which can be discarded if the patient recovers renal function within three months.
  2. Acute kidney injury (AKI). Most of these patients will recover within three months, so the questionnaire can wait, and be filled in retrospectively for the few remaining patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Month 至 95 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients starting maintenance dialysis therapies at the participating centers

排除标准

  • 未提供

结局指标

主要结局

Proportion of patients who start planned dialysis initiation as defined by the protocol

时间窗: 1 year

Planned dialysis The patient's first dialysis is planned if: 1. His first hemodialysis uses an AV fistula 2. His first hemodialysis uses a permanent catheter as the patient's permanent access 3. His first peritoneal dialysis is \>6 days after catheter placement. The patient's first dialysis is unplanned if: 1. His first hemodialysis uses a temporary catheter 2. His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned. 3. His first peritoneal dialysis is \<7 days after catheter placement.

次要结局

  • Choice of dialysis access(1 year)
  • Death(1 year)
  • Choice of dialysis modality(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

James heaf

Doctor

Herlev Hospital

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
Estudio con pacientes en prediálisis y diálisis renal para evaluar la seguridad, tolerabilidad e inmunogenicidad de la vacuna recombinante contra la hepatitis B fabricada mediante un proceso modificado A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured with a Modified Process - Estudio en diálisis de la vacuna de la Hepatitis B (recombinante)Hepatitis B
EUCTR2006-003650-20-ESMerck Sharp & Dohme de España, S.A.276
进行中(未招募)
不适用
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiency
EUCTR2006-003650-20-ITMerck and Co Inc.276
进行中(未招募)
1 期
A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis BVaccine Manufactured with a Modified Process - Hepatitis B Vaccine (Recombinant) Dialysis StudyHepatitis BMedDRA version: 8.1Level: LLTClassification code 10019731Term: Hepatitis B
EUCTR2006-003650-20-GBMerck & Co Inc.,276
Unknown
不适用
The Effects of Pre-transplant Dialysis Modality on Post-transplant EventsDelayed Function of Renal TransplantPrimary Nonfunction of Renal TransplantAcute Rejection of Renal Transplant
NCT01513707Ha Young Oh1,040
Unknown
3 期
Preop Hemodialysis or Intraop Ultrafiltration for Patients With Severe Renal Dysfunction Undergoing Open Heart SurgeryNon-Dialysis Dependent Severe Renal DysfunctionCardiovascular Disease
NCT00720967University Hospital, Geneva450